Watson Exits Medicaid Drug Inflation MDL For $79M
Watson Pharmaceuticals Inc. on Wednesday agreed to pay $79 million to settle part of a Massachusetts multidistrict litigation accusing it and other pharmaceutical companies of overcharging Medicaid by reporting inflated drug...To view the full article, register now.
Already a subscriber? Click here to view full article